Perlecan mediates the antiproliferative effect of apolipoprotein E on smooth muscle cells. An underlying mechanism for the modulation of smooth muscle cell growth? (Q54069183)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Perlecan mediates the antiproliferative effect of apolipoprotein E on smooth muscle cells. An underlying mechanism for the modulation of smooth muscle cell growth?	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10593935

Perlecan mediates the antiproliferative effect of apolipoprotein E on smooth muscle cells. An underlying mechanism for the modulation of smooth muscle cell growth? (English)

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10593935

1 reference

based on heuristic

inferred from title

author name string

Paka L

1

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10593935

Goldberg IJ

2

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10593935

Obunike JC

3

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10593935

Choi SY

4

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10593935

Saxena U

5

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10593935

Goldberg ID

6

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10593935

Pillarisetti S

7

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10593935

language of work or name

0 references

publication date

1 December 1999

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10593935

Journal of Biological Chemistry

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10593935

274

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10593935

51

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10593935

36403-36408

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10593935

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Cultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growth

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Sequence-independent inhibition of in vitro vascular smooth muscle cell proliferation, migration, and in vivo neointimal formation by phosphorothioate oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Lysolecithin-induced alteration of subendothelial heparan sulfate proteoglycans increases monocyte binding to matrix

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Relationship between perlecan and tropoelastin gene expression and cell replication in the developing rat pulmonary vasculature

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Perlecan regulates Oct-1 gene expression in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: an adhesion modulated by glycosaminoglycan

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Proliferation and the monoclonal origins of atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Structural and functional characterization of the human perlecan gene promoter. Transcriptional activation by transforming growth factor-beta via a nuclear factor 1-binding element

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Developmental regulation of perlecan gene expression in aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Binding of beta-VLDL to heparan sulfate proteoglycans requires lipoprotein lipase, whereas ApoE only modulates binding affinity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than e4.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Heparinase III limits rat arterial smooth muscle cell proliferation in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Suppression by heparin of smooth muscle cell proliferation in injured arteries

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Apolipoprotein E containing high density lipoprotein stimulates endothelial production of heparan sulfate rich in biologically active heparin-like domains. A potential mechanism for the anti-atherogenic actions of vascular apolipoprotein e

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Arterial heparan sulfate proteoglycans inhibit vascular smooth muscle cell proliferation and phenotype change in vitro and neointimal formation in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Structural characterization of heparan sulfate proteoglycan subclasses isolated from bovine aortic endothelial cell cultures

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Characterization of proteoglycans synthesized by cultured corneal fibroblasts in response to transforming growth factor beta and fetal calf serum

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Basement-membrane heparan sulfate proteoglycan binds to laminin by its heparan sulfate chains and to nidogen by sites in the protein core

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Heparin-like molecules regulate the number of epidermal growth factor receptors on vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Perlecan in human bone marrow: a growth-factor-presenting, but anti-adhesive, extracellular matrix component for hematopoietic cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Heparan sulfate proteoglycans mediate a potent inhibitory signal for migration of vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Thrombin reduces large heparan sulfate proteoglycan molecules in cultured vascular endothelial cell layers through inhibition of core protein synthesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein. Further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Molecular interactions of the syndecan core proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.51.36403

21 January 2018

Identifiers

10.1074/JBC.274.51.36403

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10593935

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10593935

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54069183&oldid=2165487365"